Clinical effect of Saccharomyces Blasti on neonatal jaundice
布拉氏酵母菌佐治新生儿黄疸的临床疗效

摘要

目的 探究布拉氏酵母菌佐治新生儿黄疸的临床疗效。方法 选择时间为2021年10月至2022年10月，我院收治的新生儿黄疸患者100例，依据不同治疗方式划分成观察组（间断蓝光照射治疗联合布拉氏酵母菌佐治的方式）;对照组（间断蓝光照射治疗），各50例。比较分析两组间的疾病疗效、不良反应发生情况等。结果 观察组中治疗总有效率48例（96.00%）高于对照组34例（68.00%），差异有统计学意义（P＜0.05）；观察组的腹泻、皮疹、发热1例（2.00%）明显低于对照组的9例（18.00%），差异有统计学意义（P＜0.05）。结论 针对新生儿黄疸患者，通过采用布拉氏酵母菌佐治模式，将有效降低不良反应的发生，提升新生儿黄疸治疗效果，适合应用于临床推广。

Abstract

Objective To explore the clinical effect of Saccharomycete Blasti on neonatal jaundice.
Methods 100 cases of neonatal jaundice patients admitted to our hospital from October 2021 to October 2022 were selected and divided into observation group according to different treatment methods (intermittent blue light irradiation combined with Saccharomycera blasti adjuvant treatment). Control group (intermittent blue light irradiation treatment), 50 cases. The effects of disease and the occurrence of adverse reactions between the two groups were compared and analyzed.
Results The total effective rate of 48 cases (96.00%) in the observation group was higher than that of 34 cases (68.00%) in the control group, the difference was statistically significant (P < 0.05). The diarrhea, rash and fever in the observation group (1 case, 2.00%) were significantly lower than those in the control group (9 cases, 18.00%), and the difference was statistically significant (P < 0.05).
Conclusion   For the patients with neonatal jaundice, the use of saccharomycete Blasti adjuvant mode can effectively reduce the occurrence of adverse reactions and improve the therapeutic effect of neonatal jaundice, which is suitable for clinical promotion.